 | • レポートコード：B-GIR09D4206 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、プレリキサフォーの世界市場について調べ、まとめました。種類別セグメントは、24MG / 1.2ML、タイプII等、用途別セグメントは、非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者等に区分しました。プレリキサフォーの世界市場概観、企業動向、企業別プレリキサフォーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・プレリキサフォーの市場概観 ・プレリキサフォーの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・プレリキサフォーの企業別販売動向、市場シェア、市場集中度、競争動向 ・プレリキサフォーの世界市場規模 ・プレリキサフォーの北米市場分析（アメリカ、カナダ、メキシコ等） ・プレリキサフォーのアメリカ市場規模推移 ・プレリキサフォーのカナダ市場規模推移 ・プレリキサフォーのメキシコ市場規模推移 ・プレリキサフォーのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・プレリキサフォーのドイツ市場規模推移 ・プレリキサフォーのイギリス市場規模推移 ・プレリキサフォーのロシア市場規模推移 ・プレリキサフォーのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・プレリキサフォーの日本市場規模推移 ・プレリキサフォーの中国市場規模推移 ・プレリキサフォーの韓国市場規模推移 ・プレリキサフォーのインド市場規模推移 ・プレリキサフォーの東南アジア市場規模推移 ・プレリキサフォーの南米市場分析（ブラジル、アルゼンチン等） ・プレリキサフォーの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・プレリキサフォーの種類別分析/販売量、売上、市場シェア（24MG / 1.2ML、タイプII） ・プレリキサフォーの用途別分析/市場規模（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者） ・プレリキサフォーの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・プレリキサフォーの販売チャネル・代理店・貿易業者・ディーラー分析 |
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.
Scope of the Report:
The global Plerixafor market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Plerixafor.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Plerixafor market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Plerixafor market by product type and applications/end industries.
Market Segment by Companies, this report covers
sanofi-aventis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
24MG/1.2ML
Type II
Market Segment by Applications, can be divided into
Non-Hodgkin’s lymphoma (NHL) Patients
Multiple myeloma (MM) Patients
Table of Contents
1 Plerixafor Market Overview
1.1 Product Overview and Scope of Plerixafor
1.2 Classification of Plerixafor by Types
1.2.1 Global Plerixafor Revenue Comparison by Types (2019-2024)
1.2.2 Global Plerixafor Revenue Market Share by Types in 2018
1.2.3 24MG/1.2ML
1.2.4 Type II
1.3 Global Plerixafor Market by Application
1.3.1 Global Plerixafor Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Non-Hodgkin’s lymphoma (NHL) Patients
1.3.3 Multiple myeloma (MM) Patients
1.4 Global Plerixafor Market by Regions
1.4.1 Global Plerixafor Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Plerixafor Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Plerixafor Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Plerixafor Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Plerixafor Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Plerixafor Status and Prospect (2014-2024)
1.5 Global Market Size of Plerixafor (2014-2024)
2 Manufacturers Profiles
2.1 sanofi-aventis
2.1.1 Business Overview
2.1.2 Plerixafor Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 sanofi-aventis Plerixafor Revenue, Gross Margin and Market Share (2017-2018)
3 Global Plerixafor Market Competition, by Players
3.1 Global Plerixafor Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Plerixafor Players Market Share
3.2.2 Top 10 Plerixafor Players Market Share
3.3 Market Competition Trend
4 Global Plerixafor Market Size by Regions
4.1 Global Plerixafor Revenue and Market Share by Regions
4.2 North America Plerixafor Revenue and Growth Rate (2014-2019)
4.3 Europe Plerixafor Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Plerixafor Revenue and Growth Rate (2014-2019)
4.5 South America Plerixafor Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Plerixafor Revenue and Growth Rate (2014-2019)
5 North America Plerixafor Revenue by Countries
5.1 North America Plerixafor Revenue by Countries (2014-2019)
5.2 USA Plerixafor Revenue and Growth Rate (2014-2019)
5.3 Canada Plerixafor Revenue and Growth Rate (2014-2019)
5.4 Mexico Plerixafor Revenue and Growth Rate (2014-2019)
6 Europe Plerixafor Revenue by Countries
6.1 Europe Plerixafor Revenue by Countries (2014-2019)
6.2 Germany Plerixafor Revenue and Growth Rate (2014-2019)
6.3 UK Plerixafor Revenue and Growth Rate (2014-2019)
6.4 France Plerixafor Revenue and Growth Rate (2014-2019)
6.5 Russia Plerixafor Revenue and Growth Rate (2014-2019)
6.6 Italy Plerixafor Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Plerixafor Revenue by Countries
7.1 Asia-Pacific Plerixafor Revenue by Countries (2014-2019)
7.2 China Plerixafor Revenue and Growth Rate (2014-2019)
7.3 Japan Plerixafor Revenue and Growth Rate (2014-2019)
7.4 Korea Plerixafor Revenue and Growth Rate (2014-2019)
7.5 India Plerixafor Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Plerixafor Revenue and Growth Rate (2014-2019)
8 South America Plerixafor Revenue by Countries
8.1 South America Plerixafor Revenue by Countries (2014-2019)
8.2 Brazil Plerixafor Revenue and Growth Rate (2014-2019)
8.3 Argentina Plerixafor Revenue and Growth Rate (2014-2019)
8.4 Colombia Plerixafor Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Plerixafor by Countries
9.1 Middle East and Africa Plerixafor Revenue by Countries (2014-2019)
9.2 Saudi Arabia Plerixafor Revenue and Growth Rate (2014-2019)
9.3 UAE Plerixafor Revenue and Growth Rate (2014-2019)
9.4 Egypt Plerixafor Revenue and Growth Rate (2014-2019)
9.5 Nigeria Plerixafor Revenue and Growth Rate (2014-2019)
9.6 South Africa Plerixafor Revenue and Growth Rate (2014-2019)
10 Global Plerixafor Market Segment by Type
10.1 Global Plerixafor Revenue and Market Share by Type (2014-2019)
10.2 Global Plerixafor Market Forecast by Type (2019-2024)
10.3 24MG/1.2ML Revenue Growth Rate (2014-2024)
10.4 Type II Revenue Growth Rate (2014-2024)
11 Global Plerixafor Market Segment by Application
11.1 Global Plerixafor Revenue Market Share by Application (2014-2019)
11.2 Plerixafor Market Forecast by Application (2019-2024)
11.3 Non-Hodgkin’s lymphoma (NHL) Patients Revenue Growth (2014-2019)
11.4 Multiple myeloma (MM) Patients Revenue Growth (2014-2019)
12 Global Plerixafor Market Size Forecast (2019-2024)
12.1 Global Plerixafor Market Size Forecast (2019-2024)
12.2 Global Plerixafor Market Forecast by Regions (2019-2024)
12.3 North America Plerixafor Revenue Market Forecast (2019-2024)
12.4 Europe Plerixafor Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Plerixafor Revenue Market Forecast (2019-2024)
12.6 South America Plerixafor Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Plerixafor Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Plerixafor Picture
Table Product Specifications of Plerixafor
Table Global Plerixafor and Revenue (Million USD) Market Split by Product Type
Figure Global Plerixafor Revenue Market Share by Types in 2018
Figure 24MG/1.2ML Picture
Figure Type II Picture
Table Global Plerixafor Revenue (Million USD) by Application (2014-2024)
Figure Plerixafor Revenue Market Share by Applications in 2018
Figure Non-Hodgkin's lymphoma (NHL) Patients Picture
Figure Multiple myeloma (MM) Patients Picture
Table Global Market Plerixafor Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Plerixafor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Plerixafor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Plerixafor Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Plerixafor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Plerixafor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Plerixafor Revenue (Million USD) and Growth Rate (2014-2024)
Table sanofi-aventis Basic Information, Manufacturing Base and Competitors
Table sanofi-aventis Plerixafor Type and Applications
Table sanofi-aventis Plerixafor Revenue, Gross Margin and Market Share (2017-2018)
Table Global Plerixafor Revenue (Million USD) by Players (2014-2019)
Table Global Plerixafor Revenue Share by Players (2014-2019)
Figure Global Plerixafor Revenue Share by Players in 2017
Figure Global Plerixafor Revenue Share by Players in 2018
Figure Global Top 5 Players Plerixafor Revenue Market Share in 2018
Figure Global Top 10 Players Plerixafor Revenue Market Share in 2018
Figure Global Plerixafor Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Plerixafor Revenue (Million USD) by Regions (2014-2019)
Table Global Plerixafor Revenue Market Share by Regions (2014-2019)
Figure Global Plerixafor Revenue Market Share by Regions (2014-2019)
Figure Global Plerixafor Revenue Market Share by Regions in 2018
Figure North America Plerixafor Revenue and Growth Rate (2014-2019)
Figure Europe Plerixafor Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Plerixafor Revenue and Growth Rate (2014-2019)
Figure South America Plerixafor Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Plerixafor Revenue and Growth Rate (2014-2019)
Table North America Plerixafor Revenue by Countries (2014-2019)
Table North America Plerixafor Revenue Market Share by Countries (2014-2019)
Figure North America Plerixafor Revenue Market Share by Countries (2014-2019)
Figure North America Plerixafor Revenue Market Share by Countries in 2018
Figure USA Plerixafor Revenue and Growth Rate (2014-2019)
Figure Canada Plerixafor Revenue and Growth Rate (2014-2019)
Figure Mexico Plerixafor Revenue and Growth Rate (2014-2019)
Table Europe Plerixafor Revenue (Million USD) by Countries (2014-2019)
Figure Europe Plerixafor Revenue Market Share by Countries (2014-2019)
Figure Europe Plerixafor Revenue Market Share by Countries in 2018
Figure Germany Plerixafor Revenue and Growth Rate (2014-2019)
Figure UK Plerixafor Revenue and Growth Rate (2014-2019)
Figure France Plerixafor Revenue and Growth Rate (2014-2019)
Figure Russia Plerixafor Revenue and Growth Rate (2014-2019)
Figure Italy Plerixafor Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Plerixafor Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Plerixafor Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Plerixafor Revenue Market Share by Countries in 2018
Figure China Plerixafor Revenue and Growth Rate (2014-2019)
Figure Japan Plerixafor Revenue and Growth Rate (2014-2019)
Figure Korea Plerixafor Revenue and Growth Rate (2014-2019)
Figure India Plerixafor Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Plerixafor Revenue and Growth Rate (2014-2019)
Table South America Plerixafor Revenue by Countries (2014-2019)
Table South America Plerixafor Revenue Market Share by Countries (2014-2019)
Figure South America Plerixafor Revenue Market Share by Countries (2014-2019)
Figure South America Plerixafor Revenue Market Share by Countries in 2018
Figure Brazil Plerixafor Revenue and Growth Rate (2014-2019)
Figure Argentina Plerixafor Revenue and Growth Rate (2014-2019)
Figure Colombia Plerixafor Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Plerixafor Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Plerixafor Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Plerixafor Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Plerixafor Revenue Market Share by Countries in 2018
Figure Saudi Arabia Plerixafor Revenue and Growth Rate (2014-2019)
Figure UAE Plerixafor Revenue and Growth Rate (2014-2019)
Figure Egypt Plerixafor Revenue and Growth Rate (2014-2019)
Figure Nigeria Plerixafor Revenue and Growth Rate (2014-2019)
Figure South Africa Plerixafor Revenue and Growth Rate (2014-2019)
Table Global Plerixafor Revenue (Million USD) by Type (2014-2019)
Table Global Plerixafor Revenue Share by Type (2014-2019)
Figure Global Plerixafor Revenue Share by Type (2014-2019)
Figure Global Plerixafor Revenue Share by Type in 2019
Table Global Plerixafor Revenue Forecast by Type (2019-2024)
Figure Global Plerixafor Market Share Forecast by Type (2019-2024)
Figure Global 24MG/1.2ML Revenue Growth Rate (2014-2019)
Figure Global Type II Revenue Growth Rate (2014-2019)
Table Global Plerixafor Revenue by Application (2014-2019)
Table Global Plerixafor Revenue Share by Application (2014-2019)
Figure Global Plerixafor Revenue Share by Application (2014-2019)
Figure Global Plerixafor Revenue Share by Application in 2019
Table Global Plerixafor Revenue Forecast by Application (2019-2024)
Figure Global Plerixafor Market Share Forecast by Application (2019-2024)
Figure Global Non-Hodgkin's lymphoma (NHL) Patients Revenue Growth Rate (2014-2019)
Figure Global Multiple myeloma (MM) Patients Revenue Growth Rate (2014-2019)
Figure Global Plerixafor Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Plerixafor Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Plerixafor Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Plerixafor Revenue Market Forecast (2019-2024)
Figure Europe Plerixafor Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Plerixafor Revenue Market Forecast (2019-2024)
Figure South America Plerixafor Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Plerixafor Revenue Market Forecast (2019-2024)
世界のホジキンリンパ腫薬市場予測（～2024年） Hodgkin's lymphoma is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may include fever, night sweats, and weight loss. Often there will be non-painful enlarged lymph nodes in the neck, under the arm, or in the groin. Those affecte…- 世界のロミプロスチム市場予測（～2024年） Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production. Scope of the Report: The global Romiplostim market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 201…
- 世界のエトラビリン市場予測（～2024年） Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etrav…
- 世界のアルモダフィニル市場予測（～2024年） Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil. Scope of the Report: The global Armodafinil market is valued at xx million USD in 2018 and is expected to reach xx million USD by th…
- 世界のルフィナミド市場予測（～2024年） Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Scope of the Report: The global Rufinamide market is valued at xx million USD in 2018 and is expected to reach xx million USD …